Related references
Note: Only part of the references are listed.Management of Late Relapses After Chemotherapy in Testicular Cancer: Optimal Outcomes with Dose-intense Salvage Chemotherapy and Surgery
Constantine Alifrangis et al.
EUROPEAN UROLOGY FOCUS (2021)
Ivermectin Augments the In Vitro and In Vivo Efficacy of Cisplatin in Epithelial Ovarian Cancer by Suppressing Akt/mTOR Signaling
Xiaohong Zhang et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2020)
YIPF2 promotes chemotherapeutic agent-mediated apoptosis via enhancing TNFRSF10B recycling to plasma membrane in non-small cell lung cancer cells
Yingying Wang et al.
CELL DEATH & DISEASE (2020)
Cyclooxygenase-2 promotes ovarian cancer cell migration and cisplatin resistance via regulating epithelial mesenchymal transition
Lin Deng et al.
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B (2020)
Downregulation of the circadian rhythm regulator HLF promotes multiple-organ distant metastases in non-small cell lung cancer through PPAR/NF-κb signaling
Jiarong Chen et al.
CANCER LETTERS (2020)
Analysis of Lung Adenocarcinoma Subtypes Based on Immune Signatures Identifies Clinical Implications for Cancer Therapy
Feng Xu et al.
MOLECULAR THERAPY-ONCOLYTICS (2020)
STAT3 rs4796793 contributes to lung cancer risk and clinical outcomes of platinum-based chemotherapy
Wei-Jing Gong et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2019)
Role of Jagged1/STAT3 signalling in platinum-resistant ovarian cancer
Jiang Yang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Understanding patients' values and preferences regarding early stage lung cancer treatment decision making
Donald R. Sullivan et al.
LUNG CANCER (2019)
Systemic Therapy for Locally Advanced and Metastatic Non-Small Cell Lung Cancer A Review
Kathryn C. Arbour et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
METase/lncRNA HULC/FoxM1 reduced cisplatin resistance in gastric cancer by suppressing autophagy
Lin Xin et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2019)
Spatial association between outdoor air pollution and lung cancer incidence in China
D. F. Xing et al.
BMC PUBLIC HEALTH (2019)
Knockdown of galectin-1 facilitated cisplatin sensitivity by inhibiting autophagy in neuroblastoma cells
Jie Gao et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2019)
Pharmacological and toxicological aspects of carbon nanotubes (CNTs) to vascular system: A review
Yi Cao et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2019)
Interaction between p53 and Ras signaling controls cisplatin resistance via HDAC4-and HIF-1α-mediated regulation of apoptosis and autophagy
Xiaofei Zhang et al.
THERANOSTICS (2019)
Chemoradiation-induced hearing loss remains a major concern for head and neck cancer patients
Nicole C. Schmitt et al.
INTERNATIONAL JOURNAL OF AUDIOLOGY (2018)
Glutathione reductase mediates drug resistance in glioblastoma cells by regulating redox homeostasis
Zhongling Zhu et al.
JOURNAL OF NEUROCHEMISTRY (2018)
Targeted iron nanoparticles with platinum-(IV) prodrugs and anti-EZH2 siRNA show great synergy in combating drug resistance in vitro and in vivo
Chang Yu et al.
BIOMATERIALS (2018)
Copper efflux transporters ATP7A and ATP7B: Novel biomarkers for platinum drug resistance and targets for therapy
Yue-Qin Li et al.
IUBMB LIFE (2018)
CD44 exerts a functional role during EMT induction in cisplatin-resistant head and neck cancer cells
Hiroaki Miyazaki et al.
Oncotarget (2018)
Down-regulation of OGT promotes cisplatin resistance by inducing autophagy in ovarian cancer
Fuxing Zhou et al.
THERANOSTICS (2018)
ABCF2, an Nrf2 target gene, contributes to cisplatin resistance in ovarian cancer cells
Lingjie Bao et al.
MOLECULAR CARCINOGENESIS (2017)
Simultaneous monitoring of the drug release and antitumor effect of a novel drug delivery system-MWCNTs/DOX/TC
Xia Dong et al.
DRUG DELIVERY (2017)
Cathepsin L upregulation-induced EMT phenotype is associated with the acquisition of cisplatin or paclitaxel resistance in A549 cells
Mei-ling Han et al.
ACTA PHARMACOLOGICA SINICA (2016)
Epithelial-mesenchymal transition: a new target in anticancer drug discovery
Fabrizio Marcucci et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
Role of mismatch repair proteins in the processing of cisplatin interstrand cross-links
Akshada Sawant et al.
DNA REPAIR (2015)
Inhibition of cisplatin-resistance by RNA interference targeting metallothionein using reducible oligo-peptoplex
Jong-Hwan Lee et al.
JOURNAL OF CONTROLLED RELEASE (2015)
pH Responsive Release of Doxorubicin to the Cancer Cells by Functionalized Multi-Walled Carbon Nanotubes
B. Anbarasan et al.
JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY (2015)
Photothermal ablation of bone metastasis of breast cancer using PEGylated multi-walled carbon nanotubes
Zhen Lin et al.
SCIENTIFIC REPORTS (2015)
Delisheng Injection (a3/4uaS⟩cYae3a°ae2), a Chinese medicinal compound, enhanced the effect of cis-platinum on lung carcinoma cell line PGCL3
Xi-lin Dong et al.
CHINESE JOURNAL OF INTEGRATIVE MEDICINE (2014)
Altered localisation of the copper efflux transporters ATP7A and ATP7B associated with cisplatin resistance in human ovarian carcinoma cells
Ganna V. Kalayda et al.
BMC CANCER (2008)
Enhanced repair of DNA interstrand crosslinking in ovarian cancer cells from patients following treatment with platinum-based chemotherapy
P. Wynne et al.
BRITISH JOURNAL OF CANCER (2007)
Nanostructured Pt functionlized multiwalled carbon nanotube based hydrogen sensor
M. Krishna Kumar et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2006)
Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals
S Ishida et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Share Paper
